Financial comparisons Peptron, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 2025-06-19			5-day change	1st Jan Change
199,700.00 ^KRW	+7.95%		+3.69%	+96.17%

2024	Peptron Signs Deal with Eli Lilly for Peptide Drug Research	MT
2023	Invex Therapeutics, Peptron End Collaboration, Manufacturing Deal	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
REGENERON PHARMACEUTICALS, INC.	14.2B	31.07%	36.33%	19.23%	15.02%	-1.12x
ARGENX SE	2.22B	36.99%	-0.96%	2.26%	2.02%	234.49x
WUXI APPTEC CO., LTD.	5.38B	24.08%	29.51%	16.78%	12.27%	-0.97x
BIONTECH SE	2.85B	-24.18%	-47.77%	-3.3%	-2.88%	9.36x
INSMED INCORPORATED	364M	-251.24%	-241.47%	-1,601.19%	-54.47%	0.16x
GENMAB A/S	2.99B	36.44%	32.53%	22.97%	19.34%	-2.97x
WUXI BIOLOGICS (CAYMAN) INC.	2.56B	17.97%	25.37%	11.65%	8.43%	-0.66x
EXELIXIS, INC.	2.17B	24.04%	27.88%	23.13%	17.7%	-1.75x
AKESO, INC.	291M	-24.22%	-26.28%	-8.94%	-4.69%	-2.82x
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	265M	-13.8%	-7.18%	-9.46%	-9.11%	3.86x
VERONA PHARMA PLC	41.93M	-410.18%	-365.73%	-	-	-
LEGEND BIOTECH CORPORATION	627M	-28.22%	-21.76%	-15.45%	-10.06%	13.02x
MADRIGAL PHARMACEUTICALS, INC.	180M	-258.64%	-276.39%	-80.35%	-	1.63x
PHARMAESSENTIA CORPORATION	297M	30.46%	17.83%	7.52%	6.63%	-9.98x
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	487M	40.03%	45.91%	30.74%	24.08%	-
BIOCON LIMITED	1.79B	6.64%	9.69%	4.89%	1.76%	4.17x
Average	2.29B	-47.67%	-47.66%	-105.3%	1.86%	17.60x
Weighted average by Cap.	4.69B	-23.75%	-27.14%	-117.1%	2.7%	33.21x